Navigation Links
Drug reduces the increase in fear caused by previous traumatic experiences in mice
Date:1/12/2011

Mice previously exposed to traumatic situations demonstrate a more persistent memory of fear conditioning - acquired by associating an acoustic stimulus with an aversive stimulus - and lack the ability to inhibit this fear. This phenomenon is similar to that of people who suffer from Post-Traumatic Stress Disorder (PTSD), an anxiety disorder which appears after being exposed to highly traumatic situations, such as a violent attack, a natural disaster or physical abuse.

In the study researchers verified that the 7,8-Dihydroxyflavone injected into mice previously subjected to a traumatic experience made them extinguish fear conditioning quicker. The enhancement of this new learning is the result of 7,8-Dihydroxyflavone activating the TrkB receptors in the brain, probably those found in the amygdala, which are essential for emotional learning and memory.

7,8-dihydroxyflavone is a type of flavonoid. These chemical compounds are present in our diets in elements such as red wine, citrus, cereals, tea and chocolate (at least 70% cocoa), etc. Chronic administration of foods rich in flavonoids in lab animals has demonstrated neuroprotective effects in aged rodents, but the activation of TrkB receptors produced by these foods is surely low compared to the effects of 7,8-Dihydroxyflavone.

TrkB receptors in the brain are activated in mammals by the BDNF protein. There are different pathologies, such as depression or anxiety disorders, in which this protein shows alterations in its function. Unfortunately, administration of the BDNF protein as a drug is limited given that a large part of the amount injected does not permeate the blood-brain barrier and cannot access the brain. Very recent studies have demonstrated that 7,8-Dihydroxyflavone is the first drug to imitate BDNF actions and enter the brain with much more efficacy than the protein, thus revealing therapeutic actions in animal models suffering from Alzheimer's, strokes, Parkinson's and/or depression.

The results obtained in this study postulate that 7,8-Dihydroxyflavone as a drug could be an useful treatment for disorders based on fear such as PTSD, panic attacks and phobias. Researchers consider it convenient to study its effects combined with psychotherapy, administering the drug in fear extinction therapy sessions for anxiety disorders or even shortly after a person experiences a traumatic situation.


'/>"/>

Contact: Antonio Armario
Antonio.Armario@uab.cat
34-935-811-840
Universitat Autonoma de Barcelona
Source:Eurekalert

Related medicine news :

1. Loss of gene promotes brain-tumor development, reduces survival, study finds
2. Study shows that CPAP therapy reduces fatigue, increases energy in patients with sleep apnea
3. Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent
4. Annual breast cancer screening beginning at age 40 reduces mastectomy risk
5. Regular exercise reduces large number of health risks including dementia and some cancers
6. Canola-type rapeseed oil reduces the level of fibrinogen, a cause of thrombosis and inflammation
7. National study shows CT screening of former, current smokers reduces lung cancer deaths
8. Cancer drug linked to quantum dots increases drug uptake, reduces inflammation
9. PSA Test Reduces Risk of Spread if Prostate Cancer Strikes
10. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
11. Vigorous exercise reduces breast cancer risk in African-American women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... PA (PRWEB) , ... April 21, 2017 , ... ... firm in Allegheny County that offers services to communities throughout the greater Pittsburgh ... in a charity drive to provide adaptive bicycles for differently-abled children. , Variety ...
(Date:4/21/2017)... City, Colo. (PRWEB) , ... April 21, 2017 , ... ... of the Flex House, the next project in the company’s esteemed VISION House demonstration ... help homeowners use exactly the amount of resources they need to live affordably and ...
(Date:4/21/2017)... ... 21, 2017 , ... The VIA Agency , a ... Theravent, Inc. , the makers of a revolutionary new device clinically proven ... now working to expand distribution in anticipation of a national launch. VIA will ...
(Date:4/21/2017)... Arvada, CO (PRWEB) , ... April 21, 2017 ... ... health and performance system, has partnered with O2X , an active lifestyle ... are focused on improving the health of firefighters, police offers, first responders, military ...
(Date:4/21/2017)... British Columbia (PRWEB) , ... April 21, 2017 , ... ... at treating people who wish to overcome their mental health struggles. The Alive team ... Director Vic LeBouthillier says: “Our approach in dealing with a mental health struggle is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Deutsche Bank Securities 42nd ... Boston, Massachusetts on Wednesday, May ... Eastern Time. A live webcast of the ... website at http://investor.zimmerbiomet.com .  The webcast will be ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology: